logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Mark Linch

university college london hospital
H指数:30
被引数:4,069

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

DURANCE: A phase Ib/II study to assess the safety and activity of durvalumab (MEDI4736) in combination with S-488210/S-488211 vaccine in non-muscle invasive bladder cancer

DURANCE：一项评估 durvalumab（MEDI4736）联合 S-488210/S-488211 疫苗在非肌层浸润性膀胱癌中的安全性与活性的 Ib/II 期研究

ANNALS OF ONCOLOGY
IF65.4
2024-12-010
PRE
Leone, G.; Shokri, A.; Szabados, B. E.; Khoo, V.; Crabb, S.; Enting, D.; Powles, T. B.; Ottensmeier, C. H. H.; Quezada, S.; Begum, R.; Musleh, R.; Duggan, M.; Rashid, M. K.; Linch, M.
A phase II study of the first-in-class oral innate immune activator BXCL701 with pembrolizumab in patients with metastatic castration-resistant prostate cancer (mCRPC): Long-term follow-up

一类口服先天免疫激活剂BXCL701联合帕博利珠单抗治疗转移性去势抵抗性前列腺癌（mCRPC）患者的II期研究：长期随访

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Aggarwal, R.; Tagawa, S. T.; Monk, P.; Zhu, X.; Jones, R. J.; Linch, M.; Costin, D.; de Bono, J. S.; Karsh, L. I.; Petrylak, D. P.; Borderies, P.; Deshpande, R.; O'Neill, V.; Zhang, J.
Pembrolizumab plus Abiraterone Acetate and Prednisone in Patients with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort D

帕博利珠单抗联合阿比特龙醋酸盐和泼尼松用于化疗初治转移性去势抵抗性前列腺癌患者：KEYNOTE-365研究D队列的结果

European Urology Oncology
IF9.3
2024-06-010
OAAI
Evan Y. Yu; Cristiano Ferrario; Mark D. Linch; Michael Stoeckle; Brigitte Laguerre; Jose A. Arranz; Tilman Todenhöfer; Peter C. Fong; Josep M. Piulats; William Berry; Urban Emmenegger; Loic Mourey; Anthony M. Joshua; Nataliya Mar; Leonard J. Appleman; Henry J. Conter; Gwenaelle Gravis; Xin Tong Li; Charles Schloss; Christian Poehlein; Johann S. de Bono
phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in non-urothelial, muscle invasive bladder cancer (ABACUS-2)

II期研究新辅助阿特珠单抗在非尿路上皮，肌肉浸润性膀胱癌中的安全性和有效性 (ABACUS-2)

ANNALS OF ONCOLOGY
IF65.4
2023-10-013
PRE
Szabados, B. E.; Nogueron Martinez, E.; Alvarez Marquez, F. J.; Castellano Gauna, D. E.; Rodriguez-Vida, A.; Garcias de Espana, M. C.; Hussain, S. A.; Alvarez Fernandez, C.; Linch, M.; Bonfill Abella, T.; Goupil, M. Gross; Kelly, J.; Jones, R. J.; Crabb, S.; Beltran, L.; Garonce-Hediger, R.; Rakebrandt, N. J.; Georgescu, R.; Ackerman, C.; Powles, T. B.
Evaluating atezolizumab in patients with urinary tract squamous cell carcinoma (AURORA): study protocol for a single arm, open-label, multicentre, phase II clinical trial

评估尿路鳞状细胞癌 (AURORA) 患者的atezolizumab: 单臂，开放标签，多中心，II期临床试验的研究方案

BMC CANCER
IF3.4
2023-09-190
OAAI
Crabb, Simon; Wickens, Robin; Jane-Bibby, Sarah; Dunkley, Denise; Lawrence, Megan; Knight, Allen; Jones, Robert; Birtle, Alison; Huddart, Robert; Linch, Mark; Martin, Jonathan; Coleman, Adam; Boukas, Konstantinos; Markham, Hannah; Griffiths, Gareth
Copy number architectures define treatment-mediated selection of lethal prostate cancer clones
NATURE COMMUNICATIONS
IF15.7
2023-08-102
OAAI
Hasan, A. M. Mahedi; Cremaschi, Paolo; Wetterskog, Daniel; Jayaram, Anuradha; Wong, Stephen Q.; Williams, Scott; Pasam, Anupama; Trigos, Anna; Trujillo, Blanca; Grist, Emily; Friedrich, Stefanie; Vainauskas, Osvaldas; Parry, Marina; Ismail, Mazlina; Devlies, Wout; Wingate, Anna; Linch, Mark; Naceur-Lombardelli, Cristina; Swanton, Charles; Jamal-Hanjani, Mariam; Lise, Stefano; Sandhu, Shahneen; Attard, Gerhardt
Updated analysis of CANCAP03 - A study into the pharmacodynamic biomarker effects of olaparib (PARP inhibitor) ± degarelix (GnRH antagonist) given prior to radical prostatectomy
CANCER RESEARCH
IF16.6
2023-06-020
PRE
Dev, Harveer; Linch, Mark; Kynaston, Howard; Shaw, Greg; Narahari, Krishna; Hernandez, Tatiana; Warren, Anne; Malaviya, Alopa; Harrington, Elizabeth; Glont, Silvia; Sqautrito, Massimo; Armenia, Joshua; Moore, Luiza; Hanson, Robert; Milne-Clarke, Toby; Anand, Shubha; Massie, Charlie; Shah, Nimish; Pacey, Simon
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial (vol 25, pg 1706, 2019)
NATURE MEDICINE
IF50
2023-03-210
OA
Powles, Thomas; Kockx, Mark; Rodriguez-Vida, Alejo; Duran, Ignacio; Crabb, Simon J.; van der Heijden, Michiel S.; Szabados, Bernadett; Pous, Albert Font; Gravis, Gwenaelle; Herranz, Urbano Anido; Protheroe, Andrew; Ravaud, Alain; Maillet, Denis; Mendez, Maria Jose; Suarez, Cristina; Linch, Mark; Prendergast, Aaron; van Dam, Pieter-Jan; Stanoeva, Diana; Daelemans, Sofie; Mariathasan, Sanjeev; Tea, Joy S.; Mousa, Kelly; Banchereau, Romain; Castellano, Daniel
Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder
EUROPEAN UROLOGY
IF25.2
2022-08-0182
OA
Szabados, Bernadett; Kockx, Mark; Assaf, Zoe June; van Dam, Pieter-Jan; Rodriguez-Vida, Alejo; Duran, Ignacio; Crabb, Simon J.; Van Der Heijden, Michiel S.; Pous, Albert Font; Gravis, Gwenaelle; Herranz, Urbano Anido; Protheroe, Andrew; Ravaud, Alain; Maillet, Denis; Mendez, Maria Jose; Suarez, Cristina; Linch, Mark; Prendergast, Aaron; Tyson, Charlotte; Stanoeva, Diana; Daelemans, Sofie; Rombouts, Miche; Mariathasan, Sanjeev; Tea, Joy S.; Mousa, Kelly; Sharma, Shruti; Aleshin, Alexey; Banchereau, Romain; Castellano, Daniel; Powles, Thomas
Pembrolizumab Plus Docetaxel and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort B Study

Pembrolizumab联合多西他赛和泼尼松治疗转移性去势抵抗性前列腺癌患者: 1b/2期主题365队列B研究的长期结果

EUROPEAN UROLOGY
IF25.2
2022-07-0144
OA
Yu, Evan Y.; Kolinsky, Michael P.; Berry, William R.; Retz, Margitta; Mourey, Loic; Piulats, Josep M.; Appleman, Leonard J.; Romano, Emanuela; Gravis, Gwenaelle; Gurney, Howard; Bogemann, Martin; Emmenegger, Urban; Joshua, Anthony M.; Linch, Mark; Sridhar, Srikala; Conter, Henry J.; Laguerre, Brigitte; Massard, Christophe; Li, Xin Tong; Schloss, Charles; Poehlein, Christian H.; de Bono, Johann S.
Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF_SELECT consortium assay
NAR CANCER
IF3.2
2022-05-279
OAAI
Orlando, Francesco; Romanel, Alessandro; Trujillo, Blanca; Sigouros, Michael; Wetterskog, Daniel; Quaini, Orsetta; Leone, Gianmarco; Xiang, Jenny Z.; Wingate, Anna; Tagawa, Scott; Jayaram, Anuradha; Linch, Mark; Jamal-Hanjani, Mariam; Swanton, Charles; Rubin, Mark A.; Wyatt, Alexander W.; Beltran, Himisha; Attard, Gerhardt; Demichelis, Francesca
Toxicity and Surgical Complication Rates of Neoadjuvant Atezolizumab in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy: Updated Safety Results from the ABACUS Trial

接受根治性膀胱切除术的肌层浸润性膀胱癌患者新辅助阿特珠单抗的毒性和手术并发症发生率: ABACUS试验的最新安全性结果

EUROPEAN UROLOGY ONCOLOGY
IF9.3
2021-06-0123
PRE
Szabados, Bernadett; Rodriguez-Vida, Alejo; Duran, Ignacio; Crabb, Simon J.; Van der Heijden, Michiel S.; Pous, Albert Font; Gravis, Gwenaelle; Herranz, Urbano Anido; Protheroe, Andrew; Ravaud, Alain; Maillet, Denis; Mendez-Vidal, Maria J.; Suarez, Cristina; Linch, Mark; Prendergast, Aaron; Tyson, Charlotte; Mousa, Kelly; Castellano, Daniel; Powles, Thomas

研究方向

暂未获取到该数据
P
Peter J. Parker
H 指数:105论文数:642被引数:4.2万
S
Simon J. Crabb
H 指数:45论文数:326被引数:9,048
N
Neil Q. McDonald
H 指数:52论文数:183被引数:1.6万
T
Thomas Powles
H 指数:77论文数:690被引数:3.6万
P
Philippe Riou
H 指数:29论文数:118被引数:2,725
G
Gwénaëlle Gravis
H 指数:65论文数:736被引数:2.3万
M
Michiel S. van der Heijden
H 指数:53论文数:341被引数:2.6万
B
Bernadett Szabados
H 指数:24论文数:216被引数:3,620
A
Alejo Rodríguez‐Vida
H 指数:32论文数:227被引数:6,027
C
Carine Rossé
H 指数:27论文数:47被引数:4,448